Ratnesh Kumar Singh
机构:Lineage Cell Therapeutics (United States) · ORCID:0000-0002-7085-447X
发表论文 33 篇 · 总被引 579 次 · h-index 15
代表论文
- Limitations and Promise of Retinal Tissue From Human Pluripotent Stem Cells for Developing Therapies of Blindness (2020 · Frontiers in Cellular Neuroscience · 被引 66)
- Pluripotent Stem Cells for Retinal Tissue Engineering: Current Status and Future Prospects (2018 · Stem Cell Reviews and Reports · 被引 63)
- Characterization of Three-Dimensional Retinal Tissue Derived from Human Embryonic Stem Cells in Adherent Monolayer Cultures (2015 · Stem Cells and Development · 被引 60)
- Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in the Subretinal Space of the Cat Eye (2019 · Stem Cells and Development · 被引 55)
- Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of COX7A1 in embryonic and cancer cells (2017 · Oncotarget · 被引 50)
- Dnmt1, Dnmt3a and Dnmt3b cooperate in photoreceptor and outer plexiform layer development in the mammalian retina (2016 · Experimental Eye Research · 被引 45)